| Ongoing Symptoms, Formation of Interstitial Lung Disease and Follow-up Process in PostCOVID-19 | Ceyda ANAR, Melike Yüksel YAVUZ | 53–65 |
| Pulmonary Rehabilitation and COVID-19 | Hülya DOĞAN ŞAHİN | 66–74 |
| Characteristics of COVID-19 Pneumonia Cases Treated withFavipiravir in the Chest Diseases Clinic | Aydan MERTOĞLU, Ali Kadri ÇIRAK, Yelda VAROL, Gülistan KARADENİZ, Enver YALNIZ, Gülru POLAT, Aysu AYRANCI, Serir ÖZKAN, Burçin HAKANOĞLU, Fevziye TUKSAVUL, Celalettin YILMAZ | 75–81 |
| The Effect of Lung Cancer and Chemotherapy on Sleep Quality and Quality of Life | Tuğba GÖKTALAY, Yavuz HAVLUCU, Deniz KIZILIRMAK, Pınar ÇELİK, Ökkeş GÜLTEKİN | 82–90 |
| Relationship Between CRP, D-Dimer, D-Dimer/CRP with Clinical Probability and Diagnostic Value in Patients with Suspected Pulmonary Thoromboembolism | Cenk BABAYİĞİT, Nursel DİKMEN, Yunus GÜNKAN | 91–97 |
| Successful Treatment of Severe ARDS Developed AfterLobectomy By Using Extracorporeal Membrane Oxygenation | Murat HALİLOĞLU, Aybüke KEKEÇOĞLU, Burcu İlerİ FİKRİ, Özkan DEVRAN | 98–102 |
| Acute Lung Toxicity Due to Nitrofurantoin Use: With A Case | Meltem YILMAZ, Arif İŞCAN, Levent Cem MUTLU | 103–108 |
| Scalp Metastasis of Mesothelioma | Berna Eren KÖMÜRCÜOĞLU, Eylem YILDIRIM, İlkin YETİŞKİN | 109–112 |